|
|
|
LifeScienceHistory.com - Check us out on Instagram
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
XORI Corporation
| XORI Corporation 430 East 29th Street New York, NY 10016 | |
| | Phone: | (206) 957-7300 | Fax: | (206) 957-7399 | Year Established: | 2009 | Employees: | 6 | | Company Description | XORI (chore-ee) will focus on a unique technology for the rapid discovery and development of monoclonal antibodies (MAbs). XORI will validate the technology on a variety of targets and develop superior products for cancer therapy, immune disorders, and infectious diseases.
XORI was founded by Dr. Nancy Maizels, a professor in the Immunology and Biochemistry Departments and also Director of the Molecular Medicine Program at the University of Washington. Dr. Maizels’ laboratory has developed a proprietary technology for the rapid evolution of monoclonal antibodies. This new technology enables the evolution and selection of high affinity antibodies specific for virtually any target. XORI will be able to identify high affinity monoclonal antibodies within a matter of weeks, as opposed to the more traditional methods which require many months and often fail to generate high quality reagents. | |
|
|
|
|
|